Frederic “Rick” Sax, M.D. leads advisory solutions for product development – leveraging design expertise at every step of the drug development spectrum to help partners make knowledge-based decisions about the benefit-risk-value trade-offs of their compounds.
Dr. Sax joined Quintiles from AstraZeneca’s clinical development leadership team where he served as Vice President, Clinical Design Strategies. For more than a decade, Dr. Sax has led the design of solutions to enhance the quality of program and trial design while driving efficiencies in cost, time and process. Dr. Sax’s career spans nearly 20 years in the biopharmaceutical industry. Prior to joining the industry, he served as an academic cardiologist. Dr. Sax graduated with a B.A. in Biology and Philosophy from Yale University, and an M.D. from Columbia University.